Oncotelic Therapeutics Integrates AI, Nanomedicine, and Robotics to Boost Precision Oncology and Rare Disease Treatments
Oncotelic Therapeutics is leveraging its PDAOAI ecosystem, Deciparticle nanomedicine platform, and robotics to accelerate therapies for cancer and rare diseases, positioning itself at the forefront of precision oncology and automation.
